TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2025-02-05
公報種別公開国際商標公報
国際登録番号1824942
国際登録日2024-05-06
区分第5類(薬剤),第10類(医用機器)
商品役務Pharmaceutical preparations, formulations, or suspensions for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, embolic particles; pharmaceutical preparations for embolization therapy.,Medical apparatus and instruments for embolization; embolic devices for treating anomalies vasculature of the body; medical device, namely, vascular embolization device; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; differentiated particle embolics (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical device for vascular embolization procedures; organ ischemia or infarction interventions (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations, or occlusion of blood flow in the peripheral vasculature; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in medical and surgical procedures comprised of embolic particles therefore (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical apparatus, namely全 22 件を表示, system for vascular embolization procedures; embolic devices and kits for vascular embolization and peripheral hemostasis, namely, embolization therapy system, featuring embolic particles.
基礎出願番号98258262
基礎出願日2023-11-07
基礎出願国US
出願人Instylla, Inc.
OCRテキストEMBAKC
OCRテキスト2
OCRについて
この商標をJ-PlatPatで参照する

関連商標

GlaxoSmithKline Biologicals S.A.
EXFLUNA
7日前
GlaxoSmithKline Biologicals S.A.
RIXFLUGO
7日前
BLUE SAIL MEDICAL CO., LTD.
28日前
Ohly GmbH
7日前
PROPEDIX, INC.
7日前
個人
7日前
RTI Surgical, Inc.
7日前
Bayer Aktiengesellschaft
7日前
Brixton Biosciences, Inc.
14日前
Alteya Organics LLC
7日前
NOVARTIS AG
7日前
NovoGlia, Inc.
14日前
ClichemBIO, Inc.
14日前
Y-mAbs Therapeutics, Inc
14日前
Compagnie Gervais Danone
14日前
MEDTRADE PRODUCTS LIMITED
14日前
Novartis AG
7日前
SEEGENE, INC.
7日前
Bayer Aktiengesellschaft
7日前
INSUD PHARMA, S.L.
14日前
RTI Surgical, Inc.
7日前
Janssen Pharmaceutica NV
7日前
PLANTTECH BIOTECHNOLOGY SPAIN SOCIEDAD LIMITADA
7日前
Autolus Limited
Autolus
7日前
CASTELLO MONTE VIBIANO VECCHIO S.r.l.
M+PERFORMANCE
7日前
Madrigal Pharmaceuticals, Inc.
MADRIGAL
7日前
Bayer Aktiengesellschaft
HERQOLVI
7日前
Bayer Aktiengesellschaft
QITOLBY
7日前
Bayer Aktiengesellschaft
CEYAVI
7日前
VENTER PHARMA, S.L.
MucoTEST
7日前
Kailera Therapeutics, Inc.
kailera
7日前
BILLIE BOB INTERNATIONAL PTY LTD
SNACKTACULAR
7日前
Modere UK Limited
14日前
CASTELLO MONTE VIBIANO VECCHIO S.r.l.
M+
7日前
Rizhao kidspal Food Co., LTD.
14日前
SANOFI PASTEUR
28日前
続きを見る